Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages

Life Sciences

Volumn 73, Issue 11, 2003, Pages 1401-1412

  Lee, Dong Ung ^a   Kang, Young Jin ^b   Park, Min Kyu ^b   Lee, Young Soo ^b   Seo, Han Geuk ^b   Kim, Tae Sung ^c   Kim, Cheorl Ho ^d   Chang, Ki Churl ^b  

^a Dongguk University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Chonnam National University   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

Berberine alkaloids; Inducible nitric oxide synthase; Inflammation; PGE2

Indexed keywords

13 ETHYLBERBERINE; 13 METHYLBERBERINE; ALKYL GROUP; BERBERINE; BERBERINE DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INFECTION; INFLAMMATORY DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SPLEEN CELL; TRANSCRIPTION REGULATION; TUMOR;

BACTERIA (MICROORGANISMS); COPTIDIS;

EID: 0038150869     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00435-1     Document Type: Article

References (28)

1. Akhter M.H., Sabir M., Bhide N.K. Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. Indian Journal of Medical Research. 65(1):1977;133-141.
2. Chung S.W., Kang B.Y., Kim S.H., Pak Y.K., Cho D., Trinchieri G., Kim T.S. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. Journal of Biological Chemistry. 275(42):2000;32681-32687.
3. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. Journal of Experimental Medicine. 186(1):1997;39-45.
4. Dutta N.K., Marker P.H., Rao N.R. Berberine in toxin-induced experimental cholera. British Journal Pharmacology. 44(1):1972;153-159.
5. Forstermann U., Nakane M., Tracey W.R., Pollock J.S. Isoforms of nitric oxide synthase: functions in the cardiovascular system. European Heart Journal. 14(Suppl. 1):1993;10-15.
6. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., Fujiwara H. Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Medica. 65(4):1999;381-383.
7. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. Journal of Ethnopharmacology. 66(2):1999;227-233.
8. Germann T., Szeliga J., Hess H., Storkel S., Podlaski F.J., Gately M.K., Schmitt E., Rude E. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proceedings of the National Academy of Sciences of the United States of America. 92(11):1995;4823-4827.
9. Hahn F.E., Ciak J. Berberine. Antibiotics. 3:1975;577-584.
10. Hasko G., Szabo C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. British Journal of Pharmacology. 127(6):1999;1295-1304.
11. Huang F.P., Niedbala W., Wei X.Q., Xu D., Feng G.J., Robinson J.H., Lam C., Liew F.Y. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology. 28(12):1998;4062-4070.
12. Iwasa K., Nanba H., Lee D.U., Kang S.I. Structure-activity relationships of protoberberines having antimicrobial activity. Planta Medica. 64(8):1998;748-751.
13. Iwasa K., Moriyasu M., Yamori T., Turuo T., Lee D.U., Wiegrebe W. In Vitro cytotoxicity of the protoberberine-type alkaloids. Journal of Natural Products. 64(7):2001;896-898.
14. Kang Y.J., Koo E.B., Lee Y.S., Yun-Choi H.S., Chang K.C. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages. British Journal of Pharmacology. 128(2):1999;357-364.
15. Kang B.Y., Chung S.W., Cho D., Kim T.S. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochemical Pharmacology. 63(10):2002;1901-1910.
16. Kim T.S., DeKruyff R.H., Rupper R., Maecker H.T., Levy S., Umetsu D.T. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. Journal of Immunology. 158(9):1997;4137-4144.
17. Kim T.S., Kim K.M., Shin B.A., Hwang S.Y. Efficient induction of an antigen-specific, T helper type 1 immune response by interleukin-12-secreting fibroblasts. Immunology. 100(2):2000;203-208.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227(5259):1970;680-685.
19. Leonard J.P., Waldburger K.E., Schaub R.G., Smith T., Hewson A.K., Cuzner M.L., Goldman S.J. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Critical Reviews in Immunology. 17(5-6):1997;545-553.
20. Lotze M.T., Zitvogel L., Campbell R., Robbins P.D., Elder E., Haluszczak C., Martin D., Whiteside T.L., Storkus W.J., Tahara H. Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. Annals of the New York Academy of Sciences. 795:1996;440-454.
21. Makhey D., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. Protoberberine alkaloids and related compounds as dual inhibitors of mammalian topoisomerase I and II. Medicinal Chemistry Research. 5(1):1995;1-12.
22. Marletta M.A., Hurshman A.R., Rusche K.M. Catalysis by nitric oxide synthase. Current Opinion in Chemical Biology. 2(5):1998;656-663.
23. Mohan M., Pant C.R., Angra S.K., Mahajan V.M. Berberine in trachoma. (A clinical trial). Indian Journal of Ophthalmology. 30(2):1982;69-75.
24. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. Journal of Experimental Medicine. 182(5):1995;1281-1290.
25. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 95(2):1979;351-358.
26. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
27. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. Journal of Immunology. 154(9):1995;4701-4709.
28. Yamamoto K., Takase H., Abe K., Saito Y., Suzuki A. Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba. Nippon Yakurigaku Zasshi. 101(3):1993;169-175.